Status | Study |
Completed |
Study Name: Pharmacological Treatment of Rett Syndrome With Statins Condition: Rett Syndrome Date: 2015-07-20 Interventions: Drug: Lovastatin dose escallating Other Name: Mevaco |
Completed |
Study Name: Pharmacological Treatment of Rett Syndrome With Glatiramer Acetate (Copaxone) Condition: Rett Syndrome Date: 2014-05-26 Interventions: Drug: Glatiramer Acetate Other Name: Copaxone |
Completed |
Study Name: An Open Label, Exploratory Study to Investigate the Treatment Effect of Glatiramer Acetate on Girls Woth Rett Syndrome Condition: Rett Syndrome Date: 2013-12-23 Interventions: Drug: Glatiramer Acetate (Copaxone®) GA is a potent inducer of Th2-cells and modulates these immune |
Active, not recruiting |
Study Name: Study to Assess Safety and Efficacy of Fingolimod in Children With Rett Syndrome Condition: Rett's Syndrome Date: 2013-08-27 Interventions: Drug: fingolimod (FTY720) 0.5 or 0.25 mg fingolimod orally daily for each of 6 patients with rett syndro |
Completed |
Study Name: Phase 2 Study of EPI-743 for Treatment of Rett Syndrome Condition: Rett Syndrome Date: 2013-03-25 Interventions: Drug: EPI-743 |
Completed |
Study Name: Treatment of Rett Syndrome With Recombinant Human IGF-1 Condition: Rett Syndrome Date: 2013-01-23 Interventions: Drug: Recombinant Human Insulin Growth Factor 1 (rhIGF-1) |
Completed |
Study Name: A Safety Study of NNZ-2566 in Patients With Rett Syndrome Condition: Rett Syndrome Date: 2012-10-04 Interventions: Drug: NNZ-2566 Glycyl-L-2-Meth |
Completed |
Study Name: Placebo Controlled Trial of Dextromethorphan in Rett Syndrome Condition: Rett Syndrome Date: 2012-01-25 Interventions: Drug: dextromethorphan The DM |
Completed |
Study Name: Treatment of Rett Syndrome With rhIGF-1 (Mecasermin [rDNA]Injection) Condition: Rett Syndrome Date: 2010-12-02 Interventions: Drug: rhIGF-1 1) PHASE 1 (4 weeks): Subjects will receive escalating twice-daily doses of IGF-1 over 4 w |
Completed |
Study Name: Creatine Metabolism in Rett Syndrome Condition: Rett Syndrome Date: 2010-09-02 |